Simplified regulatory pathways are key for the future of biosimilars in Europe
Increasing competition and uncertain returns on investment could threaten future innovation in the biosimilar arena.
Increasing competition and uncertain returns on investment could threaten future innovation in the biosimilar arena.
Research strength, clinical capabilities, favourable regulatory policies and direct access to the Greater Bay Area are expanding Hong Kong’s value to medical-device companies, with HKSTP’s first MEDICA pavilion providing fresh...
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Australia starts investigation into OpenAI Medicare breach
Industry partnership will determine the success of the transition to low-GWP pMDIs
TrialAssure selected as EMA’s official clinical trial anonymisation partner
ASCO26: AI innovations show promise in reducing the oncology RWD burden